-
CNTA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Centessa Pharmaceuticals (CNTA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm |
Cash burn (monthly) | (no burn) | (no burn) | 15.47 mm | 13.64 mm | 7.13 mm | 10.86 mm |
Cash used (since last report) | n/a | n/a | 78.38 mm | 69.10 mm | 36.13 mm | 55.02 mm |
Cash remaining | n/a | n/a | 316.64 mm | 325.93 mm | 358.90 mm | 340.00 mm |
Runway (months of cash) | n/a | n/a | 20.5 | 23.9 | 50.3 | 31.3 |
13F holders | Current |
---|---|
Total holders | 118 |
Opened positions | 26 |
Closed positions | 14 |
Increased positions | 36 |
Reduced positions | 37 |
13F shares | Current |
---|---|
Total value | 1.93 tn |
Total shares | 164.02 mm |
Total puts | 220.10 k |
Total calls | 7.00 k |
Total put/call ratio | 31.4 |
Largest owners | Shares | Value |
---|---|---|
Medicxi Growth I | 19.96 mm | $0.00 |
Medicxi Ventures Management | 19.96 mm | $334.38 bn |
Index Ventures Life Vi | 9.96 mm | $112.17 mm |
Index Venture Life Associates VI | 9.96 mm | $166.86 bn |
General Atlantic | 9.68 mm | $162.17 bn |
Atlantic Cooperatief U.A. General | 9.68 mm | $243.11 mm |
Perceptive Advisors | 6.35 mm | $106.35 bn |
First Light Asset Management | 5.81 mm | $97.24 bn |
T. Rowe Price | 5.36 mm | $89.85 mm |
Adage Capital Partners GP, L.L.C. | 5.12 mm | $85.74 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Feb 25 | Gregory M Weinhoff | Ordinary Shares | Sell | Dispose S | No | Yes | 15.2488 | 11,494 | 175.27 k | 134,021 |
20 Feb 25 | Saurabh Saha | Ordinary Shares | Sell | Dispose S | No | Yes | 16.5426 | 775 | 12.82 k | 331,017 |
20 Feb 25 | Saurabh Saha | Ordinary Shares | Sell | Dispose S | No | Yes | 15.9201 | 54,225 | 863.27 k | 331,792 |
18 Feb 25 | Iqbal J Hussain | Ordinary Shares | Sell | Dispose S | No | Yes | 17.0527 | 1,388 | 23.67 k | 105,386 |
18 Feb 25 | Iqbal J Hussain | Ordinary Shares | Sell | Dispose S | No | Yes | 15.9142 | 4,612 | 73.40 k | 106,774 |
18 Feb 25 | Iqbal J Hussain | Ordinary Shares | Option exercise | Acquire M | No | No | 5.84 | 6,000 | 35.04 k | 111,386 |
18 Feb 25 | Iqbal J Hussain | Share Option Ordinary Shares | Option exercise | Dispose M | No | No | 5.84 | 6,000 | 35.04 k | 315,559 |
10 Feb 25 | Anderson Karen M. | Ordinary Shares | Sell | Dispose S | No | Yes | 18.99 | 429 | 8.15 k | 54,322 |
10 Feb 25 | Anderson Karen M. | Ordinary Shares | Option exercise | Acquire M | No | No | 4.01 | 429 | 1.72 k | 54,751 |
10 Feb 25 | Anderson Karen M. | Share Option Ordinary Shares | Option exercise | Dispose M | No | No | 4.01 | 429 | 1.72 k | 244,035 |